Features
Advances in Low-Vision Research
New technologies and initiatives are improving quality of life for these patients.
By Susan L. Worley, contributing writer
Faricimab Shows Potential for 16-Week Dosing
Initial data presented from Genentech’s STAIRWAY study.
Surgical Management of Proliferative Diabetic Retinopathy
Considerations and treatment approaches.
New Insight Into Obstructive Sleep Apnea and Diabetic Retinopathy
Treating OSA may stop or reverse retinal disease progression.
Decision Making in Diabetic Retinopathy Treatment
A variety of tools enable individualized care.
Imaging Diabetic Patients With Swept-Source Optical Coherence Tomography
Key advantages for the patient and practice.
Subthreshold Laser Treatment of Retinal Diseases
A potential alternative for treating center-involving macular edema.
CODING Q&A: Clarity Comes to Modifier 24
What defines an unrelated procedure?
CLINICAL TRIAL DOWNLOAD: Discussing New Abicipar Pegol Data
Experts explore 12-week dosing and inflammation rates.
RETINA CONVERSATIONS: A Conversation With Thomas A. Ciulla, MD, MBA
A journey from academia to the corporate world.
UVEITIS CORNER: Applications of OCT Angiography in Uveitis
A useful tool for retina specialists to diagnose and monitor disease.
NEW PRODUCT APPLICATIONS: The Perfect Pairing of UWF and OCT
Ultrawidefield imaging combined with optical coherence tomography provide superior imaging.
Making History
Exploring Luxturna gene therapy and its surgical delivery
What Are We Missing?
Steps for developing an educational program to help reduce missed amd diagnoses
All the Right Moves
If putting down roots means relocating your practice, here are some tips for a smooth transition
MARKETING MATTERS
Connecting with Your Community
CODING CORNER
Coding Reassessment for Complex Retinal Detachment Repair